Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys

L. A. Burgos-Briceno, Andrew V Schally, A. Bartke, R. H. Asch

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The effects of single and repeated administration of a potent LHRH inhibitory analog (antagonist) ([N-acetyl-D-p-chloro-Phe1,2,D-Trp3,D-Arg6,D-Ala10]LHRH) on serum concentrations of LH and testosterone (T) in adult rhesus monkeys were studied. In Exp 1, single sc injections of the LHRH antagonist (400 μg and 50 μg) or vehicle were administered and the temporal changes in serum LH and T were determined (n = 4 per group). Both LH and T declined markedly in all animals as soon as 30 min after the LHRH antagonist injection, reaching the nadir (80%) approximately 8 h later and remaining significantly lower than baseline levels for up to 24 h. Control animals had no marked variations in either LH or T serum levels. In Exp 2, daily sc injections of different doses of LHRH antagonist (400 μg, 50 μg, and 10 μg) or vehicle were administered for 7 days to four animals in each group. The animals in the control group had no significant changes in LH or T levels, whereas those treated with the lowest dose of LHRH antagonist (10 μg) had decreased T levels in the absence of changes in LH. The other two doses of LHRH antagonist (400 μg and 50 μg) induces, as early as 8 h after the initial injection, dramatic decreases in serum levels of both LH and T and these values remained significantly lower than control for up to 3 and 4 days after discontinuation of drug administration, respectively. We conclude from this study that LHRH inhibitory analogs are potent inhibitors of LH and T in adult rhesus monkeys. They have potential use in clinical trials for male contraception as well as in patients in whom inhibition of gonadotropin and steroid secretion is desired.

Original languageEnglish
Pages (from-to)601-607
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume59
Issue number4
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Luteinizing Hormone
Macaca mulatta
Gonadotropin-Releasing Hormone
Testosterone
Serum
Animals
Injections
Gonadotropins
Contraception
Steroids
Clinical Trials
Control Groups
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys. / Burgos-Briceno, L. A.; Schally, Andrew V; Bartke, A.; Asch, R. H.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 59, No. 4, 01.01.1984, p. 601-607.

Research output: Contribution to journalArticle

@article{34edf9b40bd749ae9e92565d6f833cc5,
title = "Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys",
abstract = "The effects of single and repeated administration of a potent LHRH inhibitory analog (antagonist) ([N-acetyl-D-p-chloro-Phe1,2,D-Trp3,D-Arg6,D-Ala10]LHRH) on serum concentrations of LH and testosterone (T) in adult rhesus monkeys were studied. In Exp 1, single sc injections of the LHRH antagonist (400 μg and 50 μg) or vehicle were administered and the temporal changes in serum LH and T were determined (n = 4 per group). Both LH and T declined markedly in all animals as soon as 30 min after the LHRH antagonist injection, reaching the nadir (80{\%}) approximately 8 h later and remaining significantly lower than baseline levels for up to 24 h. Control animals had no marked variations in either LH or T serum levels. In Exp 2, daily sc injections of different doses of LHRH antagonist (400 μg, 50 μg, and 10 μg) or vehicle were administered for 7 days to four animals in each group. The animals in the control group had no significant changes in LH or T levels, whereas those treated with the lowest dose of LHRH antagonist (10 μg) had decreased T levels in the absence of changes in LH. The other two doses of LHRH antagonist (400 μg and 50 μg) induces, as early as 8 h after the initial injection, dramatic decreases in serum levels of both LH and T and these values remained significantly lower than control for up to 3 and 4 days after discontinuation of drug administration, respectively. We conclude from this study that LHRH inhibitory analogs are potent inhibitors of LH and T in adult rhesus monkeys. They have potential use in clinical trials for male contraception as well as in patients in whom inhibition of gonadotropin and steroid secretion is desired.",
author = "Burgos-Briceno, {L. A.} and Schally, {Andrew V} and A. Bartke and Asch, {R. H.}",
year = "1984",
month = "1",
day = "1",
language = "English",
volume = "59",
pages = "601--607",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys

AU - Burgos-Briceno, L. A.

AU - Schally, Andrew V

AU - Bartke, A.

AU - Asch, R. H.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - The effects of single and repeated administration of a potent LHRH inhibitory analog (antagonist) ([N-acetyl-D-p-chloro-Phe1,2,D-Trp3,D-Arg6,D-Ala10]LHRH) on serum concentrations of LH and testosterone (T) in adult rhesus monkeys were studied. In Exp 1, single sc injections of the LHRH antagonist (400 μg and 50 μg) or vehicle were administered and the temporal changes in serum LH and T were determined (n = 4 per group). Both LH and T declined markedly in all animals as soon as 30 min after the LHRH antagonist injection, reaching the nadir (80%) approximately 8 h later and remaining significantly lower than baseline levels for up to 24 h. Control animals had no marked variations in either LH or T serum levels. In Exp 2, daily sc injections of different doses of LHRH antagonist (400 μg, 50 μg, and 10 μg) or vehicle were administered for 7 days to four animals in each group. The animals in the control group had no significant changes in LH or T levels, whereas those treated with the lowest dose of LHRH antagonist (10 μg) had decreased T levels in the absence of changes in LH. The other two doses of LHRH antagonist (400 μg and 50 μg) induces, as early as 8 h after the initial injection, dramatic decreases in serum levels of both LH and T and these values remained significantly lower than control for up to 3 and 4 days after discontinuation of drug administration, respectively. We conclude from this study that LHRH inhibitory analogs are potent inhibitors of LH and T in adult rhesus monkeys. They have potential use in clinical trials for male contraception as well as in patients in whom inhibition of gonadotropin and steroid secretion is desired.

AB - The effects of single and repeated administration of a potent LHRH inhibitory analog (antagonist) ([N-acetyl-D-p-chloro-Phe1,2,D-Trp3,D-Arg6,D-Ala10]LHRH) on serum concentrations of LH and testosterone (T) in adult rhesus monkeys were studied. In Exp 1, single sc injections of the LHRH antagonist (400 μg and 50 μg) or vehicle were administered and the temporal changes in serum LH and T were determined (n = 4 per group). Both LH and T declined markedly in all animals as soon as 30 min after the LHRH antagonist injection, reaching the nadir (80%) approximately 8 h later and remaining significantly lower than baseline levels for up to 24 h. Control animals had no marked variations in either LH or T serum levels. In Exp 2, daily sc injections of different doses of LHRH antagonist (400 μg, 50 μg, and 10 μg) or vehicle were administered for 7 days to four animals in each group. The animals in the control group had no significant changes in LH or T levels, whereas those treated with the lowest dose of LHRH antagonist (10 μg) had decreased T levels in the absence of changes in LH. The other two doses of LHRH antagonist (400 μg and 50 μg) induces, as early as 8 h after the initial injection, dramatic decreases in serum levels of both LH and T and these values remained significantly lower than control for up to 3 and 4 days after discontinuation of drug administration, respectively. We conclude from this study that LHRH inhibitory analogs are potent inhibitors of LH and T in adult rhesus monkeys. They have potential use in clinical trials for male contraception as well as in patients in whom inhibition of gonadotropin and steroid secretion is desired.

UR - http://www.scopus.com/inward/record.url?scp=0021182050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021182050&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 601

EP - 607

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -